Uniphar (LON:UPR) Hits New 52-Week High - Here's What Happened

Shares of Uniphar plc (LON:UPR - Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as GBX 284 ($3.77) and last traded at GBX 279.09 ($3.71), with a volume of 1825 shares traded. The stock had previously closed at GBX 280 ($3.72).

Analysts Set New Price Targets

Separately, Shore Capital reaffirmed a "buy" rating on shares of Uniphar in a research report on Tuesday, February 25th.

Uniphar Stock Up 2.2%

The company has a debt-to-equity ratio of 119.48, a current ratio of 0.90 and a quick ratio of 0.60. The firm's 50-day moving average is GBX 238.75 and its 200 day moving average is GBX 204.94. The stock has a market cap of £887.15 million, a price-to-earnings ratio of 19.82 and a beta of 0.75.

Uniphar Increases Dividend

The business also recently declared a dividend, which was paid on Friday, May 16th. Investors of record on Thursday, April 24th were given a dividend of €0.01 ($0.01) per share. This is a positive change from Uniphar's previous dividend of $0.01. The ex-dividend date of this dividend was Thursday, April 24th. This represents a yield of 0.47%. Uniphar's dividend payout ratio is 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.